Vizient/AACN Nurse Residency ProgramTM Coordinator Call - Casey-Fink Survey Updates
During the call, Dr. Casey will present on the history of the Casey Fink survey, including the factors in decision to update the survey. She is going to outline new survey domains and share results from some of the early testing of the new questions and new domains. She will discuss the timeline for rolling out the survey as well as answer general questions from the attendees about the survey.
Target Audience
Nursing
Learning Objectives
1. Describe the history of the Casey-Fink survey development.
2. Discuss 2022 Casey-Fink survey revision process.
3. Appraise tools to measure program outcomes.
Additional Information
Attachment | Size |
---|---|
07-28-2022 - Information for CE Credit - Live.docx | 125.1 KB |
Helpful Tips for Users - Vizient CE System.pdf | 134.81 KB |
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
DISCLOSURE STATEMENTS:
Absence of Relevant Financial Relationships
None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Planning committee members
Meg Ingram, MSN, RN
NRP Programmatic Advisor
Vizient
Angela Renkema, MPH, BSN, RN, NPD-BC, RN-BC, CPH
NRP Programmatic Advisor Director
Vizient
Evy Olson, MSN, MBA, RN
AVP, Nursing Programs
Vizient
Megan Buckley
Program Manager, Nurse Residency Program
Vizient
Shannon Hale, MHA, RN, CPHQ
NRP Programmatic Advisor
Vizient
Course reviewer
Meg Ingram, MSN, RN
Vizient approved nurse planner
NRP Programmatic Advisor
Vizient
Presenter(s)
Kathryn Casey, PhD, RN, NPD-BC
Professional Development Specialist & Nurse Residency Program Coordinator
Denver Health
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement:
NURSING
This activity is designated for 1.00 contact hours.
Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.00 contact hours
Available Credit
- 1.00 ANCC
- 1.00 CBRN